Pfizer

Stories 121 - 140 | << Prev   Next >>

Third Strong Vaccine May Have Big Advantage

AstraZeneca's candidate is up to 90% effective, and it can be easily stored and shipped

(Newser) - A third COVID vaccine candidate is reporting strong results —and this one would be easier to transport and store than the first two. AstraZeneca says interim results show that its vaccine is up to 90% effective, slightly less than the 95% reported by Pfizer and Moderna . But while its...

Warp Speed Boss Has Target Date for First Shot

Immunizations could begin Dec. 12, Slaoui says

(Newser) - The head of the US effort to produce a coronavirus vaccine says the first immunizations could happen on Dec. 12. A Food and Drug Administration advisory committee is set to meet Dec. 10 to discuss Pfizer Inc.'s request for an emergency use authorization for its developing COVID-19 vaccine....

Pfizer Makes Big Move as a Different COVID Record Falls

Number of US hospitalizations exceeds 80K for first time

(Newser) - The next big step toward a COVID vaccine took place on Friday. Pfizer formally sought US regulators' approval of its vaccine, which has shown to be 95% effective in clinical trials, reports the AP and STAT News . FDA scientists are expected to give the green light for distribution in a...

Why Demand for Dry Ice Is Soaring
Why Demand for
Dry Ice Is Soaring
Nov 18, 2020 2:11 PM CST

Why Demand for Dry Ice Is Soaring

Pfizer vaccine needs to be store at ultracold temperature

(Newser) - Demand for dry ice is off the charts—and it's not because of a resurgence in heavy metal concerts. Pfizer and BioNTech's coronavirus vaccine, which could receive emergency use authorization from the FDA within days , needs to be stored at -112 degrees Fahrenheit to be effective. That temperature...

Final Analysis of Pfizer's Vaccine Trials Even Better

Final analysis of late-stage trials shows it's 95% effective, with no major safety worries

(Newser) - More good news from Pfizer and BioNTech, its German partner in the race to produce a coronavirus vaccine: They're expecting to seek an emergency use OK from the Food and Drug Administration "within days," per a statement cited by CNN . That's due to a final analysis...

Trump Resurfaces to Tout Vaccine
Trump
Emerges
to Tout
Vaccine
UPDATED
Nov 13, 2020 5:19 PM CST

Trump Emerges to Tout Vaccine

Rose Garden comments don't include a concession to Biden

(Newser) - Gliding over significant challenges still to come, President Trump on Friday offered a rosy update on the race for a vaccine for the resurgent coronavirus as he delivered his first public remarks since his defeat by President-elect Joe Biden. Trump still did not concede the election, and he did not...

Pfizer CEO Sold Big Chunk of Shares on Day of Vaccine News

He sold $5.6M in shares as price soared

(Newser) - Pfizer CEO Albert Bourla sold a big chunk of his shares on the same day the company announced very promising news on a coronavirus vaccine , according to an SEC filing. Bourla sold shares worth $5.6 million as the company's stock price soared on Monday, but the company says...

What Fauci Thinks About Pfizer Vaccine

'Extraordinary,' he says, and explains why the news is doubly good

(Newser) - Anthony Fauci isn't mincing words when it comes to the coronavirus vaccine Pfizer has on the horizon . "The results are really quite good, I mean extraordinary," said the director of the National Institute of Allergy and Infectious Diseases. He added that that might also be good news...

&#39;Dream Team&#39; Couple Are Behind New Vaccine
'Dream Team' Couple Helped
Develop New Vaccine
THE RUNDOWN
Nov 9, 2020 3:23 PM CST

'Dream Team' Couple Helped Develop New Vaccine

Huge challenges will await after approval

(Newser) - The exhilarating news that a COVID-19 vaccine was a big success in a large-scale trial is a victory for Pfizer—and for the husband-and-wife team behind BioNTech, the German biotech firm that collaborated with the American drugmaker. CEO Ugur Sahin and his wife, board member Oezlem Tuereci, founded the firm...

Donald Trump Jr. Thinks Vaccine News Is a Little Fishy

He suggests Pfizer delayed news to benefit Joe Biden

(Newser) - Pfizer's announcement that its vaccine appears to deliver strong protection against COVID-19 was hailed as great news in the stock market and beyond. But Donald Trump Jr. sees a political conspiracy at play, suggesting that the company held off on the news to hurt his father's reelection chances,...

Pfizer Reports Big News on Early Vaccine Results

Preliminary data shows it's 90% effective

(Newser) - Pfizer says early data suggest its COVID vaccine works—in a big way. The company said Monday that its vaccine appears to be 90% effective in preventing infections, without serious side effects, reports the New York Times . A big qualification: These are early results, and the numbers could drop as...

Pfizer's Update on Vaccine Is a 'Shift in Tone'

Announcement on application for emergency authorization predicts late November at the earliest

(Newser) - Last month, President Trump hinted that a COVID-19 vaccine could be available before Election Day, but the latest news from one of the leading developers seems to make that possibility even more remote. As the Wall Street Journal reports, Pfizer CEO Albert Bourla posted an open letter Friday announcing that,...

In Race for Vaccine, a Cold Truth
In Race for
Vaccine, a
Cold Truth
Sep 18, 2020 12:23 PM CDT

In Race for Vaccine, a Cold Truth

There may not be enough freezers icy enough to store the shots

(Newser) - "Do we have enough freezers?" That's a question many may not be pondering now, but it's an important one when it comes to a COVID-19 vaccine, per the Wall Street Journal . That's because the inoculation samples that may soon emerge might need to be stored at...

'I Am a Normal, Un-Brave Person.' And Patient 1133

Want a return to normal? Enroll in a vaccine trial, writes Molly Jong-Fast

(Newser) - "I am a normal, un-brave person. I am also a part of history now," writes Molly Jong-Fast, an editor-at-large for the Daily Beast and "Patient 1133" in Pfizer's coronavirus vaccine trial. In a New York Times op-ed, Jong-Fast describes the pride she felt (well, after the...

Bill Gates: US Pandemic Response is 'Shocking'

He also doesn't expect a vaccine before Election Day

(Newser) - Bill Gates has some bad news for President Trump, who has suggested that a coronavirus vaccine could be available by Election Day. Gates tells CNBC that he doesn't see it happening. "None of the vaccines are likely to seek approval in the US before the end of October,...

These Americans Will Get a Vaccine First
These Americans Will 
Get a Vaccine First
in case you missed it
Sep 6, 2020 10:10 AM CDT

These Americans Will Get a Vaccine First

In hypothetical plan, CDC lays out guidelines on distribution, to start as early as next month

(Newser) - Public health officials across the country have been told to prepare to distribute a coronavirus vaccine as soon as late October—though the CDC says this is just a hypothetical. In documents sent to health authorities in all states and territories, as well as five major cities (New York, Chicago,...

Dow Jones Is Removing Its Oldest Member

Exxon Mobil is among 3 leaving in shake-up

(Newser) - Three companies are departing the Dow Jones Industrial Average—including Exxon Mobil, currently the oldest member of the influential 30-company stock index. The oil giant, which joined the index in 1928 as Standard Oil, will be leaving along with Pfizer and Raytheon in the Dow's biggest shake-up since 2013,...

Operation Warp Speed Counts a Vaccine Win

Government will pay $1.95B for 100M doses, expected by year's end

(Newser) - The US has inked a deal that will have the country receiving the first 100 million doses of a coronavirus vaccine candidate in the works from Pfizer and German biotech firm BioNTech SE. The government could nab an additional 500 million doses under the agreement, which will see the US...

In Quest for COVID Vaccine, 107K 'Medical Heroes' Emerge

Volunteers coming out in droves to help 4 firms planning on starting phase 3 of clinical trials in fall

(Newser) - In early July, the National Institutes of Health launched a clinical trials network through which it hoped to enroll thousands of volunteers to test potential COVID-19 vaccines. Just a week or so later, more than 107,000 people had signed up. That's a number USA Today says will "...

'I Feel Fantastic,' COVID-19 Vaccine Volunteer Says

Woman in Seattle trial reports no major side effects but still wears a mask to be sure

(Newser) - The first person in the US to receive an experimental vaccine for COVID-19 has provided a medical update, and it's encouraging. "It's been 16 weeks since I had the first dose," Jennifer Haller says. "I feel fantastic." The Washington state woman, an operations manager...

Stories 121 - 140 | << Prev   Next >>
Most Read on Newser